XOMA (US) LLC /
LadRx Corporation
XOMA secures royalty and milestone rights from LadRx Corporation
- Price
- $5m
- Stage
- Agreement signed
What happened
XOMA (US) LLC entered into agreements with LadRx Corporation for rights to milestone payments and royalties tied to arimoclomol and aldoxorubicin.
XOMA paid LadRx $5 million in the aggregate, with up to $6 million in additional milestone payments possible subject to certain conditions.
The source
Everything on this page comes from the source below.
XOMA secures royalty and milestone rights from LadRx Corporation
This document is the source for the companies, stage, figure and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly